Question 1

What are the potential side effects of Dolutegravir compared to other HIV medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) clinical trial (NCT03327740). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this study help me understand the safety of my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) clinical trial (NCT03327740). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I do if I experience any allergic reactions or liver issues?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) clinical trial (NCT03327740). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to be monitored during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) clinical trial (NCT03327740). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there other treatment options I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) clinical trial (NCT03327740). Contact the study team or your healthcare provider for specific answers.

Question 6

What are the risks of not participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) clinical trial (NCT03327740). Contact the study team or your healthcare provider for specific answers.

What this study is about